首页 > 最新文献

Journal of Traditional Chinese Medicine最新文献

英文 中文
In comparison with vitamin C and butylated hydroxytoluene, the antioxidant capacity of aqueous extracts from buds and flowers of Lonicera japonica Thunb. 与维生素C和丁基羟基甲苯比较,金银花花蕾水提物的抗氧化能力。
IF 2.6 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2018-06-01 Epub Date: 2018-08-17 DOI: 10.1016/S0254-6272(18)30627-7
Zhou Yunfeng , Li Lin , Sun Lan , Zhou Lidong , Xu Yang

OBJECTIVE

To assess the antioxidant capacity of aqueous extracts of buds and flowers of Lonicera japonica Thunb. (BLJ and FLJ) using in vitro assays.

METHODS

We assessed the in vitro antioxidant activities of aqueous extracts of BLJ and FLJ and compared with that of classical antioxidants vitamin C and butylated hydroxytoluene, using several well-established methods including the 1,1-diphenyl-2-picryl-hydrazyl assay, 2,2'-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) assay, reducing power assay, fluorescence recovery after photo-bleaching assay, β-carotene bleaching assay, ferric thiocyanate assay, and thiobarbituric acid method.

RESULTS

The aqueous extracts of both BLJ and FLJ had similarly potent antioxidant capacity. There were no significance differences between BLJ and FLJ in all the assays.

CONCLUSION

The aqueous extracts of both BLJ and FLJ have antioxidant activity with comparable efficacy. These findings suggest that both BLJ and FLJ may have the potential as natural antioxidants.

目的评价金银花花蕾水提物的抗氧化能力。(BLJ和FLJ)。方法采用1,1-二苯基-2-苦味酰肼法、2,2′-氮基-双(3-乙基苯并噻唑-6-磺酸)法、还原力法、光漂白后荧光恢复法、β-胡萝卜素漂白法、硫氰酸铁法、硫代巴比托酸法等方法,对BLJ和FLJ水提物的体外抗氧化活性进行评价,并与经典抗氧化剂维生素C和丁基羟基甲苯的体外抗氧化活性进行比较。结果牛膝姜和牛膝姜的水提物均具有较强的抗氧化能力。BLJ和FLJ在所有试验中均无显著性差异。结论枸杞多糖和茯苓多糖水提物均具有抗氧化活性,且具有相当的抗氧化效果。这些发现表明,BLJ和FLJ可能都有作为天然抗氧化剂的潜力。
{"title":"In comparison with vitamin C and butylated hydroxytoluene, the antioxidant capacity of aqueous extracts from buds and flowers of Lonicera japonica Thunb.","authors":"Zhou Yunfeng ,&nbsp;Li Lin ,&nbsp;Sun Lan ,&nbsp;Zhou Lidong ,&nbsp;Xu Yang","doi":"10.1016/S0254-6272(18)30627-7","DOIUrl":"10.1016/S0254-6272(18)30627-7","url":null,"abstract":"<div><h3>OBJECTIVE</h3><p>To assess the antioxidant capacity of aqueous extracts of buds and flowers of Lonicera japonica Thunb. (BLJ and FLJ) using <em>in vitro</em> assays.</p></div><div><h3>METHODS</h3><p>We assessed the <em>in vitro</em> antioxidant activities of aqueous extracts of BLJ and FLJ and compared with that of classical antioxidants vitamin C and butylated hydroxytoluene, using several well-established methods including the 1,1-diphenyl-2-picryl-hydrazyl assay, 2,2'-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) assay, reducing power assay, fluorescence recovery after photo-bleaching assay, β-carotene bleaching assay, ferric thiocyanate assay, and thiobarbituric acid method.</p></div><div><h3>RESULTS</h3><p>The aqueous extracts of both BLJ and FLJ had similarly potent antioxidant capacity. There were no significance differences between BLJ and FLJ in all the assays.</p></div><div><h3>CONCLUSION</h3><p>The aqueous extracts of both BLJ and FLJ have antioxidant activity with comparable efficacy. These findings suggest that both BLJ and FLJ may have the potential as natural antioxidants.</p></div>","PeriodicalId":17513,"journal":{"name":"Journal of Traditional Chinese Medicine","volume":"38 3","pages":"Pages 373-379"},"PeriodicalIF":2.6,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0254-6272(18)30627-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46602436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Protective effects of Jiayan Kangtai granules on autoimmune thyroiditis in a rat model by modulating Th17/Treg cell balance 佳炎康泰颗粒通过调节Th17/Treg细胞平衡对自身免疫性甲状腺炎模型大鼠的保护作用
IF 2.6 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2018-06-01 Epub Date: 2018-08-17 DOI: 10.1016/S0254-6272(18)30628-9
Hou Yi , Wang Tieshan , Guo Xiangyu , Sun Wen , Guo Xuan , Wu Lili , Qin Lingling , Zhang Chengfei , Liu Tonghua

OBJECTIVE

To investigate the protective effects of Jiayan Kangtai (JYKT) granules, consisting of 9 Chinese herbs, in a rat model of autoimmune thyroiditis (AIT), and the possible underlying mechanism.

METHODS

Female Lewis rats (6–8 weeks) were randomly apportioned to 5 groups of 10, including a normal control. AIT was induced in the untreated AIT-model group, and rats treated subsequently with daily low, medium, or high dose JYKT granules. After 12 weeks, plasma levels of thyroid autoantibodies and morphological changes in the thyroid were detected by enzyme-linked immunosorbent assay and histological examination, respectively. The presence of interleukin (IL)-6, IL23p19, and IL-2 in thyroid tissue was assessed by immunohistochemical staining. The percentages of T helper (Th)17 cells and regulatory T cells (Tregs) in the peripheral blood were analyzed by flow cytometry. Relevant levels of cytokines and proteins were examined via bead-based multiplex flow cytometry and ELISA, respectively. Expressions of genes and proteins regulated by Th17 cells and Tregs were shown by real-time PCR and Western blot.

RESULTS

Compared to the control, AIT-model rats had higher plasma concentrations of thyroid autoantibodies. The high-dose JYKT rats showed significantly lower levels of thyroid autoantibodies compared with the AIT model group. Rats in the AIT-JYKT groups also had fewer thyroid lesions and less lymphocytic infiltration, a lower percentage of Th17 cells, and a higher percentage of Tregs, compared with the AIT-model. Rats given high-dose JYKT had a significantly lower Th17/Treg ratio compared with the AIT model. Differences in plasma cytokine concentrations and relevant gene and protein expressions in the spleens of JYKT-treated rats and the AIT group suggested an association between JYKT treatment and lower Th17 cell percentage and higher Treg activity.

CONCLUSION

JYKT treatment appeared to be protective against AIT in rats, possibly via the regulation of the Th17 cell/Treg imbalance in AIT.

目的探讨9味中药复方佳炎康泰颗粒对自身免疫性甲状腺炎(AIT)大鼠模型的保护作用及其可能的机制。方法6 ~ 8周龄雌性Lewis大鼠随机分为5组,每组10只,其中正常对照组1只。未处理AIT模型组大鼠诱导AIT,随后每日给予低、中、高剂量JYKT颗粒。12周后,分别用酶联免疫吸附法和组织学检查检测血浆甲状腺自身抗体水平和甲状腺形态学变化。免疫组化染色检测甲状腺组织中白细胞介素(IL)-6、IL- 23p19和IL-2的表达。流式细胞术检测外周血辅助性T细胞(Th)17和调节性T细胞(Tregs)的百分比。通过流式细胞术和酶联免疫吸附法分别检测细胞因子和蛋白的相关水平。实时荧光定量PCR和Western blot检测Th17细胞和Tregs调控的基因和蛋白的表达情况。结果与对照组相比,ait模型大鼠血浆甲状腺自身抗体浓度升高。与AIT模型组相比,高剂量JYKT大鼠甲状腺自身抗体水平明显降低。与ait模型相比,AIT-JYKT组大鼠甲状腺病变较少,淋巴细胞浸润较少,Th17细胞百分比较低,treg细胞百分比较高。与AIT模型相比,高剂量JYKT大鼠Th17/Treg比值明显降低。JYKT处理大鼠和AIT组血浆细胞因子浓度及脾脏相关基因和蛋白表达的差异表明,JYKT处理与较低的Th17细胞百分比和较高的Treg活性有关。结论jykt对大鼠AIT具有保护作用,可能是通过调节AIT中Th17细胞/Treg失衡来实现的。
{"title":"Protective effects of Jiayan Kangtai granules on autoimmune thyroiditis in a rat model by modulating Th17/Treg cell balance","authors":"Hou Yi ,&nbsp;Wang Tieshan ,&nbsp;Guo Xiangyu ,&nbsp;Sun Wen ,&nbsp;Guo Xuan ,&nbsp;Wu Lili ,&nbsp;Qin Lingling ,&nbsp;Zhang Chengfei ,&nbsp;Liu Tonghua","doi":"10.1016/S0254-6272(18)30628-9","DOIUrl":"10.1016/S0254-6272(18)30628-9","url":null,"abstract":"<div><h3>OBJECTIVE</h3><p>To investigate the protective effects of Jiayan Kangtai (JYKT) granules, consisting of 9 Chinese herbs, in a rat model of autoimmune thyroiditis (AIT), and the possible underlying mechanism.</p></div><div><h3>METHODS</h3><p>Female Lewis rats (6–8 weeks) were randomly apportioned to 5 groups of 10, including a normal control. AIT was induced in the untreated AIT-model group, and rats treated subsequently with daily low, medium, or high dose JYKT granules. After 12 weeks, plasma levels of thyroid autoantibodies and morphological changes in the thyroid were detected by enzyme-linked immunosorbent assay and histological examination, respectively. The presence of interleukin (IL)-6, IL23p19, and IL-2 in thyroid tissue was assessed by immunohistochemical staining. The percentages of T helper (Th)17 cells and regulatory T cells (Tregs) in the peripheral blood were analyzed by flow cytometry. Relevant levels of cytokines and proteins were examined <em>via</em> bead-based multiplex flow cytometry and ELISA, respectively. Expressions of genes and proteins regulated by Th17 cells and Tregs were shown by real-time PCR and Western blot.</p></div><div><h3>RESULTS</h3><p>Compared to the control, AIT-model rats had higher plasma concentrations of thyroid autoantibodies. The high-dose JYKT rats showed significantly lower levels of thyroid autoantibodies compared with the AIT model group. Rats in the AIT-JYKT groups also had fewer thyroid lesions and less lymphocytic infiltration, a lower percentage of Th17 cells, and a higher percentage of Tregs, compared with the AIT-model. Rats given high-dose JYKT had a significantly lower Th17/Treg ratio compared with the AIT model. Differences in plasma cytokine concentrations and relevant gene and protein expressions in the spleens of JYKT-treated rats and the AIT group suggested an association between JYKT treatment and lower Th17 cell percentage and higher Treg activity.</p></div><div><h3>CONCLUSION</h3><p>JYKT treatment appeared to be protective against AIT in rats, possibly <em>via</em> the regulation of the Th17 cell/Treg imbalance in AIT.</p></div>","PeriodicalId":17513,"journal":{"name":"Journal of Traditional Chinese Medicine","volume":"38 3","pages":"Pages 380-390"},"PeriodicalIF":2.6,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0254-6272(18)30628-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41717740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Observation of changes in the number of myocardial capillaries in rabbits after treatment of acute myocardial infarction by Tongxinluo superfine powder 通心络超细粉治疗急性心肌梗死后家兔心肌毛细血管数量变化的观察
IF 2.6 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2018-06-01 Epub Date: 2018-08-17 DOI: 10.1016/S0254-6272(18)30631-9
Wu Haotian , Zhang Fengshun , Liu Jinyi , Li Xuezhao , Guo Fei , Wu Yiling

OBJECTIVE

To investigate the effects of Tongxinluo superfine powder on cardiac function, infarct size and the number of myocardial capillaries in a rabbit model of acute myocardial infarction.

METHODS

A total of 32 New Zealand white rabbits were randomly divided into four groups: sham operation group, model group, treatment group, and pre-treatment, the experiment of pre-treatment group was performed 6 weeks early than the treat) group, The four groups use a unified modeling technique. An acute myocardial infarction model was established through external application of 70% ferric chloride on the coronary artery. After 7 d, electrocardiogram, ultrasonography of cardiac function, micro-computed tomography, pathology and other data were collected.

RESULTS

In the treatment and pre-treatment groups, ejection fraction, left ventricular short axis shortening rate, left ventricular end-systolic diameter and cardiac output significantly improved, the number of capillaries significantly increased, and infarct size significantly decreased. In addition, the results suggest that the value of intra-ventricular pressure and the situation of electrocardiogram also changed to different degrees with the increasing of treatment of cycle.

CONCLUSION

Tongxinluo superfine powder can protect the myocardium, improve the blood supply of the myocardium and reduce the degree of myocardial injury, during acute stage of myocardial infarction.

目的观察通心络超细粉对兔急性心肌梗死模型心功能、梗死面积及心肌毛细血管数量的影响。方法将32只新西兰大白兔随机分为4组:假手术组、模型组、治疗组和预处理组,预处理组比预处理组提前6周进行实验,4组采用统一的造模技术。采用70%氯化铁外敷冠状动脉建立急性心肌梗死模型。7 d后,采集心电图、心功能超声、显微计算机断层扫描、病理等资料。结果治疗组和治疗前组患者射血分数、左室短轴缩短率、左室收缩末期内径和心输出量均显著提高,毛细血管数量显著增加,梗死面积显著减小。此外,结果表明,随着疗程的增加,心室压值和心电图情况也有不同程度的变化。结论通心络超细粉在心肌梗死急性期具有保护心肌、改善心肌血供、减轻心肌损伤程度的作用。
{"title":"Observation of changes in the number of myocardial capillaries in rabbits after treatment of acute myocardial infarction by Tongxinluo superfine powder","authors":"Wu Haotian ,&nbsp;Zhang Fengshun ,&nbsp;Liu Jinyi ,&nbsp;Li Xuezhao ,&nbsp;Guo Fei ,&nbsp;Wu Yiling","doi":"10.1016/S0254-6272(18)30631-9","DOIUrl":"10.1016/S0254-6272(18)30631-9","url":null,"abstract":"<div><h3>OBJECTIVE</h3><p>To investigate the effects of Tongxinluo superfine powder on cardiac function, infarct size and the number of myocardial capillaries in a rabbit model of acute myocardial infarction.</p></div><div><h3>METHODS</h3><p>A total of 32 New Zealand white rabbits were randomly divided into four groups: sham operation group, model group, treatment group, and pre-treatment, the experiment of pre-treatment group was performed 6 weeks early than the treat) group, The four groups use a unified modeling technique. An acute myocardial infarction model was established through external application of 70% ferric chloride on the coronary artery. After 7 d, electrocardiogram, ultrasonography of cardiac function, micro-computed tomography, pathology and other data were collected.</p></div><div><h3>RESULTS</h3><p>In the treatment and pre-treatment groups, ejection fraction, left ventricular short axis shortening rate, left ventricular end-systolic diameter and cardiac output significantly improved, the number of capillaries significantly increased, and infarct size significantly decreased. In addition, the results suggest that the value of intra-ventricular pressure and the situation of electrocardiogram also changed to different degrees with the increasing of treatment of cycle.</p></div><div><h3>CONCLUSION</h3><p>Tongxinluo superfine powder can protect the myocardium, improve the blood supply of the myocardium and reduce the degree of myocardial injury, during acute stage of myocardial infarction.</p></div>","PeriodicalId":17513,"journal":{"name":"Journal of Traditional Chinese Medicine","volume":"38 3","pages":"Pages 406-411"},"PeriodicalIF":2.6,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0254-6272(18)30631-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47199159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical practice guidelines for treating headache with Traditional Chinese Medicine: quality assessment with the appraisal of guidelines for research and evaluation II instrument 中药治疗头痛临床实践指南:质量评价与研究评价指南ⅱ
IF 2.6 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2018-06-01 Epub Date: 2018-08-17 DOI: 10.1016/S0254-6272(18)30624-1
Luo Hao , Li Hui , Wang Yangyang , Yao Sha , Xu Wenjie

OBJECTIVE

To critically appraise the methodological quality of clinical practice guidelines for headache produced over the last two decades, including those covering specific interventions using Traditional Chinese Medicine.

METHODS

The guidelines on headache disorders were obtained by searching a number of databases, including PubMed, EMBASE, Web of Science, Chinese Biomedical Literature Database, China National Knowledge Infrastructure Database, China Science and Technology Journal Database, and Wanfang database, three guideline-related databases [Guideline-International Network, National Guideline Clearinghouse, and Medlive], and the records of organizations that develop guidelines. The publication date was limited to the period from January 1996 to June 2015. The search terms “headache”, “headache disorders”, “cephalalgia”, “migraine”, “tension-type headache”, “practice guideline”, “consensus “, “statement”, “regulation”, and “recommendation” were used in the “MeSH” and “Free-text” fields. The guidelines were independently appraised by four researchers using the Appraisal of Guidelines for Research and Evaluation II instrument.

RESULTS

A total of 23 guidelines published between 1998 and 2014 were reviewed. The overall consistency of the four appraisers was good [interclass correlation coefficient 0.84; 95% confidence interval (CI) 0.82–0.86]. The mean (standard deviation) scores for scope and purpose, stakeholder involvement, rigor of development, clarity of presentation, applicability, and editorial independence were 52.1 (18.0), 39.5 (17.1), 33.4 (21.0), 49.8 (21.9), 23.8 (19.3), and 24.2 (23.7). Only two guidelines were recommended, 12 were recommended with modification, and nine were not recommended.

CONCLUSION

Physical Traditional Chinese Medicine therapies were recommended to treat headache. The overall quality of headache guidelines was low in China, but evidence-based guidelines are gradually becoming mainstream. Guideline developers should carefully consider, in particular, three domains: rigor of development, applicability, and editorial independence.

目的:批判性地评价过去二十年来制定的头痛临床实践指南的方法学质量,包括那些使用中医的特定干预措施。方法通过检索PubMed、EMBASE、Web of Science、中国生物医学文献数据库、中国国家知识基础数据库、中国科技期刊数据库、万方数据库、指南国际网、国家指南信息中心、Medlive等3个指南相关数据库以及指南制定机构的记录,获得头痛疾病指南。发布日期限于1996年1月至2015年6月期间。在“MeSH”和“Free-text”字段中使用的搜索词是“头痛”、“头痛失调”、“头痛”、“偏头痛”、“紧张性头痛”、“实践指南”、“共识”、“声明”、“规范”和“建议”。指南由四名研究人员使用研究和评估指南评估II工具进行独立评估。结果对1998 - 2014年间发表的23份指南进行了回顾。四个评价者的总体一致性较好[类间相关系数0.84;95%置信区间(CI) 0.82-0.86]。范围和目的、利益相关者参与、开发的严谨性、表述的清晰度、适用性和编辑独立性的平均(标准差)得分分别为52.1(18.0)、39.5(17.1)、33.4(21.0)、49.8(21.9)、23.8(19.3)和24.2(23.7)。只有两个指南被推荐,12个建议修改,9个不推荐。结论中药理疗是治疗头痛的有效方法。中国头痛指南的总体质量较低,但循证指南正逐渐成为主流。指南开发者应该仔细考虑,特别是三个领域:开发的严谨性、适用性和编辑独立性。
{"title":"Clinical practice guidelines for treating headache with Traditional Chinese Medicine: quality assessment with the appraisal of guidelines for research and evaluation II instrument","authors":"Luo Hao ,&nbsp;Li Hui ,&nbsp;Wang Yangyang ,&nbsp;Yao Sha ,&nbsp;Xu Wenjie","doi":"10.1016/S0254-6272(18)30624-1","DOIUrl":"https://doi.org/10.1016/S0254-6272(18)30624-1","url":null,"abstract":"<div><h3>OBJECTIVE</h3><p>To critically appraise the methodological quality of clinical practice guidelines for headache produced over the last two decades, including those covering specific interventions using Traditional Chinese Medicine.</p></div><div><h3>METHODS</h3><p>The guidelines on headache disorders were obtained by searching a number of databases, including PubMed, EMBASE, Web of Science, Chinese Biomedical Literature Database, China National Knowledge Infrastructure Database, China Science and Technology Journal Database, and Wanfang database, three guideline-related databases [Guideline-International Network, National Guideline Clearinghouse, and Medlive], and the records of organizations that develop guidelines. The publication date was limited to the period from January 1996 to June 2015. The search terms “headache”, “headache disorders”, “cephalalgia”, “migraine”, “tension-type headache”, “practice guideline”, “consensus “, “statement”, “regulation”, and “recommendation” were used in the “MeSH” and “Free-text” fields. The guidelines were independently appraised by four researchers using the Appraisal of Guidelines for Research and Evaluation II instrument.</p></div><div><h3>RESULTS</h3><p>A total of 23 guidelines published between 1998 and 2014 were reviewed. The overall consistency of the four appraisers was good [interclass correlation coefficient 0.84; 95% confidence interval (<em>CI</em>) 0.82–0.86]. The mean (standard deviation) scores for scope and purpose, stakeholder involvement, rigor of development, clarity of presentation, applicability, and editorial independence were 52.1 (18.0), 39.5 (17.1), 33.4 (21.0), 49.8 (21.9), 23.8 (19.3), and 24.2 (23.7). Only two guidelines were recommended, 12 were recommended with modification, and nine were not recommended.</p></div><div><h3>CONCLUSION</h3><p>Physical Traditional Chinese Medicine therapies were recommended to treat headache. The overall quality of headache guidelines was low in China, but evidence-based guidelines are gradually becoming mainstream. Guideline developers should carefully consider, in particular, three domains: rigor of development, applicability, and editorial independence.</p></div>","PeriodicalId":17513,"journal":{"name":"Journal of Traditional Chinese Medicine","volume":"38 3","pages":"Pages 339-350"},"PeriodicalIF":2.6,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0254-6272(18)30624-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91615216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Effect of Banxia Xiexin decoction on Helicobacter pylori-related peptic ulcers and its possible mechanism via the TGF-β/Smad signaling pathway 半夏泻心汤对幽门螺杆菌相关性消化性溃疡的影响及其TGF-β/Smad信号通路的可能机制
IF 2.6 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2018-06-01 Epub Date: 2018-08-17 DOI: 10.1016/S0254-6272(18)30633-2
Chen Shaofang , Liang Huiqing , Chen Shaodong , Huang Yanping , Wan Shichuan , Huang Yanxia

OBJECTIVE

To investigate the effect of Banxia Xiexin decoction (BXD) on Helicobacter pylori (Hp)-related peptic ulcers (PUs) and the possible mechanism underlying BXD actions via the transforming growth factor-β/small mothers against decapentaplegic (TGF-β/Smad) signaling pathway.

METHODS

PU patients with cold-heat complex syndrome were randomly assigned to groups that received Chinese or Western medicines with 20 patients in each group. Serum was collected after 7 d of treatment. The healthy group included 20 individuals. Gastric mucosal epithelial cell line GES-1 was cultured in vitro and randomly divided into the following seven groups: control, model, healthy, Western Medicine, prior treatment, low dosage, and high dosage. After 72 h of treatment with the corresponding serum, the mRNA and protein expression levels of TGF-β1, Smad3, and Smad7 were measured by reverse transcription quantitative polymerase chain reaction and western blotting, respectively.

RESULTS

The mRNA expression levels of TGF-β1 and Smad3 in GES-1 cells were increased after Hp introduction, and these increased levels were reduced by the BXD-containing serum. The protein levels of p-Smad3, but not TGF-β1 or Smad3, were significantly increased in Hp-treated GES-1 cells, and treatment with the BXD-containing serum markedly decreased the protein levels. Smad7 expression was significantly enhanced following treatment with the BXD-containing serum at transcriptional and protein levels in a dose-dependent manner.

CONCLUSION

BXD regulates the TGF-β/Smad signaling pathway by inhibiting the expression of TGF-β1 and Smad3, and increasing the expression of Smad7.

目的探讨半夏泻心汤(BXD)对幽门螺杆菌(Hp)相关消化性溃疡(PUs)的影响,并探讨BXD通过转化生长因子-β/小母抗十足瘫痪(TGF-β/Smad)信号通路作用的可能机制。方法将spu寒热复合证患者随机分为中西医结合治疗组,每组20例。治疗7 d后采集血清。健康组包括20人。体外培养胃粘膜上皮细胞系GES-1,随机分为对照组、模型组、健康组、西药组、预处理组、低剂量组、高剂量组。相应血清处理72h后,分别采用逆转录定量聚合酶链反应和western blotting检测TGF-β1、Smad3、Smad7 mRNA和蛋白表达水平。结果Hp诱导的GES-1细胞中TGF-β1和Smad3 mRNA表达水平升高,含bxd的血清降低了TGF-β1和Smad3 mRNA表达水平。hp处理的GES-1细胞中p-Smad3蛋白水平显著升高,TGF-β1和Smad3蛋白水平未见升高,含bxd的血清中p-Smad3蛋白水平显著降低。用含bxd的血清处理后,Smad7在转录和蛋白水平上以剂量依赖的方式显著增强。结论bxd通过抑制TGF-β1和Smad3的表达,提高Smad7的表达,调控TGF-β/Smad信号通路。
{"title":"Effect of Banxia Xiexin decoction on Helicobacter pylori-related peptic ulcers and its possible mechanism via the TGF-β/Smad signaling pathway","authors":"Chen Shaofang ,&nbsp;Liang Huiqing ,&nbsp;Chen Shaodong ,&nbsp;Huang Yanping ,&nbsp;Wan Shichuan ,&nbsp;Huang Yanxia","doi":"10.1016/S0254-6272(18)30633-2","DOIUrl":"10.1016/S0254-6272(18)30633-2","url":null,"abstract":"<div><h3>OBJECTIVE</h3><p>To investigate the effect of Banxia Xiexin decoction (BXD) on Helicobacter pylori (Hp)-related peptic ulcers (PUs) and the possible mechanism underlying BXD actions <em>via</em> the transforming growth factor-β/small mothers against decapentaplegic (TGF-β/Smad) signaling pathway.</p></div><div><h3>METHODS</h3><p>PU patients with cold-heat complex syndrome were randomly assigned to groups that received Chinese or Western medicines with 20 patients in each group. Serum was collected after 7 d of treatment. The healthy group included 20 individuals. Gastric mucosal epithelial cell line GES-1 was cultured <em>in vitro</em> and randomly divided into the following seven groups: control, model, healthy, Western Medicine, prior treatment, low dosage, and high dosage. After 72 h of treatment with the corresponding serum, the mRNA and protein expression levels of TGF-β1, Smad3, and Smad7 were measured by reverse transcription quantitative polymerase chain reaction and western blotting, respectively.</p></div><div><h3>RESULTS</h3><p>The mRNA expression levels of TGF-β1 and Smad3 in GES-1 cells were increased after Hp introduction, and these increased levels were reduced by the BXD-containing serum. The protein levels of p-Smad3, but not TGF-β1 or Smad3, were significantly increased in Hp-treated GES-1 cells, and treatment with the BXD-containing serum markedly decreased the protein levels. Smad7 expression was significantly enhanced following treatment with the BXD-containing serum at transcriptional and protein levels in a dose-dependent manner.</p></div><div><h3>CONCLUSION</h3><p>BXD regulates the TGF-β/Smad signaling pathway by inhibiting the expression of TGF-β1 and Smad3, and increasing the expression of Smad7.</p></div>","PeriodicalId":17513,"journal":{"name":"Journal of Traditional Chinese Medicine","volume":"38 3","pages":"Pages 419-426"},"PeriodicalIF":2.6,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0254-6272(18)30633-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46113117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Scalp-cluster acupuncture with electrical stimulation can improve motor and living ability in convalescent patients with post-stroke hemiplegia 电刺激头簇针刺可改善脑卒中后偏瘫恢复期患者的运动能力和生活能力
IF 2.6 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2018-06-01 Epub Date: 2018-08-17 DOI: 10.1016/S0254-6272(18)30638-1
Wang Xiaohong , Zhang Qi , Cui Baojuan , Sun Junhua , Ye Lan , Huang Laigang , Wang Daoqing

OBJECTIVE

To determine whether patients with post-stroke hemiplegia could benefit from long-term treatment with scalp cluster (SC) acupuncture combined with electrical stimulation (ES) and to evaluate the feasibility of this treatment to improve motor and living abilities.

METHODS

Twenty patients were enrolled and divided into two groups: SC acupuncture and SC acupuncture with ES (SC and SC + ES, respectively). All participants also received rehabilitation training. All participants were blindly evaluated using the Fugl-Meyer assessment scale for motor ability, the modified Barthel Index for living ability, and a scale for the degree of neurological deficits. Outcome was assessed at three points before randomized grouping, at the beginning or treatment, and after 4 weeks of treatment.

RESULTS

Following 4 weeks treatment, all the patients exhibited significant improvements in aspects of motor ability, living ability, and the severity of neurological deficits. The experimental group (SC + ES) scored higher on the Fugl-Meyer assessment scale (68 ± 12) and the modified Barthel Index (49 ± 9) than the control (SC) group (50 ± 13, 36 ± 13, respectively).

CONCLUSION

When patients with post-stroke hemiplegia are treated using SC acupuncture with ES, motor and living ability can improve more than if they were treated with SC acupuncture alone.

目的探讨脑卒中后偏瘫患者长期采用头皮束针联合电刺激(ES)治疗是否有益,并评价该治疗方法改善运动和生活能力的可行性。方法将20例患者分为SC针刺组和SC针刺联合ES组(分别为SC组和SC + ES组)。所有参与者还接受了康复训练。所有参与者均采用Fugl-Meyer运动能力评估量表、改良Barthel生活能力指数和神经功能缺陷程度量表进行盲测。在随机分组前、治疗开始时和治疗4周后三个时点评估结果。结果治疗4周后,所有患者的运动能力、生活能力和神经功能缺损程度均有明显改善。实验组(SC + ES)在Fugl-Meyer量表(68±12)和改良Barthel指数(49±9)上的得分分别高于对照组(50±13、36±13)。结论SC针刺联合ES治疗脑卒中后偏瘫患者的运动能力和生活能力比单纯SC针刺治疗有更大的改善。
{"title":"Scalp-cluster acupuncture with electrical stimulation can improve motor and living ability in convalescent patients with post-stroke hemiplegia","authors":"Wang Xiaohong ,&nbsp;Zhang Qi ,&nbsp;Cui Baojuan ,&nbsp;Sun Junhua ,&nbsp;Ye Lan ,&nbsp;Huang Laigang ,&nbsp;Wang Daoqing","doi":"10.1016/S0254-6272(18)30638-1","DOIUrl":"10.1016/S0254-6272(18)30638-1","url":null,"abstract":"<div><h3>OBJECTIVE</h3><p>To determine whether patients with post-stroke hemiplegia could benefit from long-term treatment with scalp cluster (SC) acupuncture combined with electrical stimulation (ES) and to evaluate the feasibility of this treatment to improve motor and living abilities.</p></div><div><h3>METHODS</h3><p>Twenty patients were enrolled and divided into two groups: SC acupuncture and SC acupuncture with ES (SC and SC + ES, respectively). All participants also received rehabilitation training. All participants were blindly evaluated using the Fugl-Meyer assessment scale for motor ability, the modified Barthel Index for living ability, and a scale for the degree of neurological deficits. Outcome was assessed at three points before randomized grouping, at the beginning or treatment, and after 4 weeks of treatment.</p></div><div><h3>RESULTS</h3><p>Following 4 weeks treatment, all the patients exhibited significant improvements in aspects of motor ability, living ability, and the severity of neurological deficits. The experimental group (SC + ES) scored higher on the Fugl-Meyer assessment scale (68 ± 12) and the modified Barthel Index (49 ± 9) than the control (SC) group (50 ± 13, 36 ± 13, respectively).</p></div><div><h3>CONCLUSION</h3><p>When patients with post-stroke hemiplegia are treated using SC acupuncture with ES, motor and living ability can improve more than if they were treated with SC acupuncture alone.</p></div>","PeriodicalId":17513,"journal":{"name":"Journal of Traditional Chinese Medicine","volume":"38 3","pages":"Pages 452-456"},"PeriodicalIF":2.6,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0254-6272(18)30638-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48655117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
What are the best Salvia miltiorrhiza injection classes for treatment of unstable angina pectoris? A systematic review and network Meta-analysis 丹参注射液治疗不稳定型心绞痛的最佳剂型有哪些?系统综述和网络元分析
IF 2.6 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2018-06-01 Epub Date: 2018-08-17 DOI: 10.1016/S0254-6272(18)30623-X
Liu Shi , Wu Jiarui , Zhang Dan , Tan Di

OBJECTIVE

To undertake a systematic review and network meta-analysis (NMA) to compare the effectiveness among the different regimens of Salvia miltiorrhiza injection classes (SMICs) for unstable angina pectoris (UAP) treatment.

METHODS

A systematic retrieval was conducted in several literature databases to identify randomized controlled trials focusing on the different regimens of SMICs for UAP treatment until January 2016. The quality assessment was accomplished according to the Cochrane risk of bias tool. Pair-wise meta-analyses were carried out by RevMan 5.3. A random-effects model of NMA was used to compare the different regimens of SMICs with regard to efficacy by STATA 13.0.

RESULTS

A total of 111 studies involving 10 500 patients were included in the NMA. The methodological quality of included studies was not high. Current evidence shows that salvianolate (SI) is the optimal treatment for UAP in improving the total efficacy against UAP. Guanxingning (GXN) is the optimal treatment for UAP for improving the total effectiveness of electrocardiography.

CONCLUSION

SMICs have advantages in preventing cardiovascular events. GXN, SI, and Danhong had the greatest probability of being the best treatment in the total efficacy against UAP and for improving the total effectiveness of electrocardiography.

目的通过系统评价和网络meta分析(NMA)比较丹参注射液类(SMICs)不同治疗方案对不稳定型心绞痛(UAP)的疗效。方法系统检索多个文献数据库,以确定截至2016年1月的不同SMICs治疗UAP方案的随机对照试验。根据Cochrane偏倚风险工具完成质量评估。采用RevMan 5.3进行双元分析。采用STATA 13.0,采用NMA随机效应模型比较SMICs不同治疗方案的疗效。结果NMA共纳入111项研究,涉及10500例患者。纳入研究的方法学质量不高。目前的证据表明,丹参酚酸(SI)是改善UAP总疗效的最佳治疗方法。冠心宁(GXN)是提高心电图总疗效的最佳治疗方法。结论smics具有预防心血管事件的优势。GXN、SI和丹红在抗UAP总疗效和提高心电图总疗效方面最有可能成为最佳治疗方案。
{"title":"What are the best Salvia miltiorrhiza injection classes for treatment of unstable angina pectoris? A systematic review and network Meta-analysis","authors":"Liu Shi ,&nbsp;Wu Jiarui ,&nbsp;Zhang Dan ,&nbsp;Tan Di","doi":"10.1016/S0254-6272(18)30623-X","DOIUrl":"10.1016/S0254-6272(18)30623-X","url":null,"abstract":"<div><h3>OBJECTIVE</h3><p>To undertake a systematic review and network meta-analysis (NMA) to compare the effectiveness among the different regimens of Salvia miltiorrhiza injection classes (SMICs) for unstable angina pectoris (UAP) treatment.</p></div><div><h3>METHODS</h3><p>A systematic retrieval was conducted in several literature databases to identify randomized controlled trials focusing on the different regimens of SMICs for UAP treatment until January 2016. The quality assessment was accomplished according to the Cochrane risk of bias tool. Pair-wise meta-analyses were carried out by RevMan 5.3. A random-effects model of NMA was used to compare the different regimens of SMICs with regard to efficacy by STATA 13.0.</p></div><div><h3>RESULTS</h3><p>A total of 111 studies involving 10 500 patients were included in the NMA. The methodological quality of included studies was not high. Current evidence shows that salvianolate (SI) is the optimal treatment for UAP in improving the total efficacy against UAP. Guanxingning (GXN) is the optimal treatment for UAP for improving the total effectiveness of electrocardiography.</p></div><div><h3>CONCLUSION</h3><p>SMICs have advantages in preventing cardiovascular events. GXN, SI, and Danhong had the greatest probability of being the best treatment in the total efficacy against UAP and for improving the total effectiveness of electrocardiography.</p></div>","PeriodicalId":17513,"journal":{"name":"Journal of Traditional Chinese Medicine","volume":"38 3","pages":"Pages 321-338"},"PeriodicalIF":2.6,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0254-6272(18)30623-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43079346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Effect of scar-producing moxibustion at the acupoints Zusanli (ST 36) and Feishu (BL 13) on neutrophil-to-lymphocyte ratio and quality of life in patients with non-small-cell lung cancer: A randomized, controlled trial 造疤灸足三里穴和肺俞穴对非小细胞肺癌患者中性粒细胞/淋巴细胞比值及生活质量的影响:一项随机对照试验
IF 2.6 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2018-06-01 Epub Date: 2018-08-17 DOI: 10.1016/S0254-6272(18)30636-8
Zhang Mengxue, Guan Ling, Wang Lili, Li Ying

OBJECTIVE

To evaluate the effect of heat stimulation via scar-producing moxibustion at the acupoints Zusanli (ST 36) and Feishu (BL 13) on the neutrophil-to-lymphocyte ratio (NLR) and quality of life in patients with non-small-cell lung cancer (NSCLC).

METHODS

Seventy patients with NSCLC were randomly assigned into two groups: group A received scar-producing moxibustion at the acupoints Zusanli (ST 36) and Feishu (BL 13) every day for 6 weeks, while group B received no intervention (control group). Outcome measures were the NLR and the scores from the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). The NLR and the EORTC QLQ-C30 were assessed at baseline and at the end of 6 weeks.

RESULTS

Five participants dropped out, leaving a final total of 65 participants who completed the trial. Groups A and B had a similar mean NLR at baseline. After the treatment course, the NLR in group A was significantly lower than that in group B (P < 0.001). Compared with group B, the EORTC QLQ-C30 scores in group A were significantly greater in terms of global health status or quality of life (P < 0.001) and function (P < 0.05), and significantly lower in terms of symptoms (P < 0.05).

CONCLUSION

The present study suggests that performing scar-producing moxibustion by heat-stimulating the acupoints Zusanli (ST 36) and Feishu (BL 13) effectively decreases the NLR and improves the quality of life in patients with NSCLC.

目的探讨热刺激生瘢痕灸足三里穴(ST 36)和肺俞穴(BL 13)对非小细胞肺癌(NSCLC)患者中性粒细胞/淋巴细胞比值(NLR)和生活质量的影响。方法70例非小细胞肺癌患者随机分为两组:A组患者每天在足三里(ST 36)和肺俞(BL 13)穴位进行造疤灸,疗程6周;B组患者不进行干预(对照组)。结果测量是NLR和欧洲癌症研究和治疗组织生活质量问卷(EORTC QLQ-C30)的分数。在基线和6周结束时评估NLR和EORTC QLQ-C30。结果5名参与者退出,最后总共有65名参与者完成了试验。A组和B组基线时的平均NLR相似。疗程结束后,A组NLR显著低于B组(P <0.001)。与B组比较,A组在整体健康状况和生活质量方面的EORTC QLQ-C30评分显著高于B组(P <0.001)和函数(P <0.05),在症状方面显著降低(P <0.05)。结论热刺激足三里穴(ST 36)和肺俞穴(BL 13)行造疤灸可有效降低NSCLC患者NLR,提高患者生活质量。
{"title":"Effect of scar-producing moxibustion at the acupoints Zusanli (ST 36) and Feishu (BL 13) on neutrophil-to-lymphocyte ratio and quality of life in patients with non-small-cell lung cancer: A randomized, controlled trial","authors":"Zhang Mengxue,&nbsp;Guan Ling,&nbsp;Wang Lili,&nbsp;Li Ying","doi":"10.1016/S0254-6272(18)30636-8","DOIUrl":"10.1016/S0254-6272(18)30636-8","url":null,"abstract":"<div><h3>OBJECTIVE</h3><p>To evaluate the effect of heat stimulation <em>via</em> scar-producing moxibustion at the acupoints Zusanli (ST 36) and Feishu (BL 13) on the neutrophil-to-lymphocyte ratio (NLR) and quality of life in patients with non-small-cell lung cancer (NSCLC).</p></div><div><h3>METHODS</h3><p>Seventy patients with NSCLC were randomly assigned into two groups: group A received scar-producing moxibustion at the acupoints Zusanli (ST 36) and Feishu (BL 13) every day for 6 weeks, while group B received no intervention (control group). Outcome measures were the NLR and the scores from the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). The NLR and the EORTC QLQ-C30 were assessed at baseline and at the end of 6 weeks.</p></div><div><h3>RESULTS</h3><p>Five participants dropped out, leaving a final total of 65 participants who completed the trial. Groups A and B had a similar mean NLR at baseline. After the treatment course, the NLR in group A was significantly lower than that in group B (<em>P</em> &lt; 0.001). Compared with group B, the EORTC QLQ-C30 scores in group A were significantly greater in terms of global health status or quality of life (<em>P</em> &lt; 0.001) and function (<em>P</em> &lt; 0.05), and significantly lower in terms of symptoms (<em>P</em> &lt; 0.05).</p></div><div><h3>CONCLUSION</h3><p>The present study suggests that performing scar-producing moxibustion by heat-stimulating the acupoints Zusanli (ST 36) and Feishu (BL 13) effectively decreases the NLR and improves the quality of life in patients with NSCLC.</p></div>","PeriodicalId":17513,"journal":{"name":"Journal of Traditional Chinese Medicine","volume":"38 3","pages":"Pages 439-446"},"PeriodicalIF":2.6,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0254-6272(18)30636-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45758900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Effect of conventional medical treatment plus Qigong exercise on type 2 diabetes mellitus in Chinese patients: A Meta-analysis 传统药物治疗加气功运动治疗2型糖尿病的meta分析
IF 2.6 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2018-04-01 Epub Date: 2018-04-21 DOI: 10.1016/j.jtcm.2018.04.002
Yang Hongchang , Wu Xueping , Wang Min

OBJECTIVE

To systematically evaluate the effect of conventional medical treatment plus Qigong exercise on type 2 diabetes mellitus (T2DM) in Chinese patients.

METHODS

A literature search was conducted in PubMed, Medline, Embase, China National Knowledge Infrastructure Database, Wanfang and China Science and Technology Journal Database until on January 2017. In this Meta-analysis, enrolled were the studies, including experimental group (with conventional medical treatment plus Qigong therapy) and control group (with conventional medical treatment plus diet control or other exercises). Then, the standardized mean differences (SMDs) of fasting blood-glucose (FBG), 2-hplasmaglucose (2hPG), hemoglobinAlc (HbAlc), triglyceride (TG), total cholesterol (TC), high-density lipoprotein (HDL) and low density lipoprotein (LDL), as well as their 95% confidence interval (CIs) were calculated to evaluate the effect of Qigong on patients with T2DM by RevMan 5.2 and Stata 11.0 software.

RESULTS

Totally 834 cases of T2DM from 11 studies were included in this review. The pooled SMDs with its 95% CIs of FBG, 2hPG, HbAlc, TG, TC, HDL and LDL were – 0.70 (– 0.93, – 0.47), – 0.66 (– 1.11, – 0.21), – 0.73 (– 0.96, – 0.50), – 1.05 (– 1.67, – 0.43), – 0.42 (– 1.12, 0.28), 0.69 (0.19, 1.19), and – 0.26 (– 0.69, 0.18), respectively. The pooled data showed significantly difference between Qigong and the levels of FBG, 2hPG, HbA1c, TG, and HDL in patients with T2DM (P < 0.05).

CONCLUSION

Combining with conventional medical treatment, Qigong exercise might have significant effect on T2DM in Chinese patients.

目的系统评价常规药物治疗加气功运动治疗2型糖尿病(T2DM)的疗效。方法检索截至2017年1月的PubMed、Medline、Embase、中国国家知识基础数据库、万方、中国科技期刊库等文献。本meta分析纳入的研究包括实验组(常规药物治疗+气功治疗)和对照组(常规药物治疗+饮食控制或其他运动)。采用RevMan 5.2和Stata 11.0软件计算空腹血糖(FBG)、2-血浆葡萄糖(2hPG)、血红蛋白alc (HbAlc)、甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白(HDL)和低密度脂蛋白(LDL)的标准化平均差值(SMDs)及其95%可信区间(CIs),评价气功对T2DM患者的影响。结果共纳入11项研究的834例T2DM患者。FBG、2hPG、HbAlc、TG、TC、HDL和LDL的95% ci汇总SMDs分别为- 0.70(- 0.93,- 0.47)、- 0.66(- 1.11,- 0.21)、- 0.73(- 0.96,- 0.50)、- 1.05(- 1.67,- 0.43)、- 0.42(- 1.12,0.28)、0.69(0.19,1.19)和- 0.26(- 0.69,0.18)。合并数据显示,气功与T2DM患者FBG、2hPG、HbA1c、TG、HDL水平有显著性差异(P <0.05)。结论气功运动与常规药物治疗相结合,对T2DM患者有显著的治疗效果。
{"title":"Effect of conventional medical treatment plus Qigong exercise on type 2 diabetes mellitus in Chinese patients: A Meta-analysis","authors":"Yang Hongchang ,&nbsp;Wu Xueping ,&nbsp;Wang Min","doi":"10.1016/j.jtcm.2018.04.002","DOIUrl":"10.1016/j.jtcm.2018.04.002","url":null,"abstract":"<div><h3>OBJECTIVE</h3><p>To systematically evaluate the effect of conventional medical treatment plus Qigong exercise on type 2 diabetes mellitus (T2DM) in Chinese patients.</p></div><div><h3>METHODS</h3><p>A literature search was conducted in PubMed, Medline, Embase, China National Knowledge Infrastructure Database, Wanfang and China Science and Technology Journal Database until on January 2017. In this Meta-analysis, enrolled were the studies, including experimental group (with conventional medical treatment plus Qigong therapy) and control group (with conventional medical treatment plus diet control or other exercises). Then, the standardized mean differences (SMDs) of fasting blood-glucose (FBG), 2-hplasmaglucose (2hPG), hemoglobinAlc (HbAlc), triglyceride (TG), total cholesterol (TC), high-density lipoprotein (HDL) and low density lipoprotein (LDL), as well as their 95% confidence interval (<em>CIs</em>) were calculated to evaluate the effect of Qigong on patients with T2DM by RevMan 5.2 and Stata 11.0 software.</p></div><div><h3>RESULTS</h3><p>Totally 834 cases of T2DM from 11 studies were included in this review. The pooled SMDs with its 95% <em>CIs</em> of FBG, 2hPG, HbAlc, TG, TC, HDL and LDL were – 0.70 (– 0.93, – 0.47), – 0.66 (– 1.11, – 0.21), – 0.73 (– 0.96, – 0.50), – 1.05 (– 1.67, – 0.43), – 0.42 (– 1.12, 0.28), 0.69 (0.19, 1.19), and – 0.26 (– 0.69, 0.18), respectively. The pooled data showed significantly difference between Qigong and the levels of FBG, 2hPG, HbA1c, TG, and HDL in patients with T2DM (<em>P</em> &lt; 0.05).</p></div><div><h3>CONCLUSION</h3><p>Combining with conventional medical treatment, Qigong exercise might have significant effect on T2DM in Chinese patients.</p></div>","PeriodicalId":17513,"journal":{"name":"Journal of Traditional Chinese Medicine","volume":"38 2","pages":"Pages 167-174"},"PeriodicalIF":2.6,"publicationDate":"2018-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jtcm.2018.04.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48556239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Effect of Dahuang Zhechong pills on long non-coding RNA growth arrest specific 5 in rat models of hepatic fibrosis 大黄浙冲丸对大鼠肝纤维化模型长链非编码RNA生长阻滞特异性5的影响
IF 2.6 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2018-04-01 Epub Date: 2018-04-21 DOI: 10.1016/j.jtcm.2018.04.007
Gong Zhenghua , Deng Chaowen , Xiang Tianxin , Tao Lili , Xiao Hongbo , Peng Yanzhong , Zheng Jie , Hu Guoxin

OBJECTIVE

To investigate the involvement of growth arrest specific 5 (GAS5), a long non-coding RNA, in the anti-hepatic fibrosis process induced by Dahuang Zhechong pill (DHZCP) in rats.

METHODS

Thirty adult rats were divided into three groups, including a control group, a CCl4-induced fibrosis group and a DHZCP-treated fibrosis group. Hematoxylin-eosin and Masson staining were used for histopathological study. Serum enzymes, cytokines and cell proliferation were assayed using commercially available kits. A GAS5 lenti-virus vector was constructed to further investigate the role of GAS5 in the anti-hepatic fibrosis effect of DHZCP in rats.

RESULTS

Our results revealed that the proliferation of hepatic stellate cells cultured in serum derived from rats treated with DHZCP was significantly decreased, compared with cells treated with serum from the untreated rats. DHZCP alleviated the CCl4-induced hepatic fibrosis. Additionally, DHZCP can restore the expression of GAS5, which was significantly decreased in the CCl4-induced group, and markedly suppress the expression of p-p38 and p-Erk induced by CCl4, but not p-Jnk. Cell proliferation was significantly arrested when cells overexpressed GAS5. Thus, DHZCP can inhibit the expression of p-p38 and p-Erk, while GAS5 can only inhibit the expression of p-Erk.

CONCLUSIONS

DHZCP can alleviate hepatic fibrosis by increasing the expression of GAS5 to suppress p-Erk and regulating other factors to inhibit p-p38.

目的探讨长链非编码RNA生长抑制特异性5 (GAS5)在大黄止血丸(DHZCP)诱导大鼠肝纤维化过程中的作用。方法30只成年大鼠分为3组,分别为对照组、ccl4诱导纤维化组和dhzcp治疗纤维化组。采用苏木精-伊红染色和马松染色进行组织病理学研究。使用市售试剂盒检测血清酶、细胞因子和细胞增殖。构建GAS5慢病毒载体,进一步研究GAS5在DHZCP抗大鼠肝纤维化中的作用。结果经DHZCP处理的大鼠血清中培养的肝星状细胞增殖能力明显低于未处理的大鼠血清。DHZCP可减轻ccl4诱导的肝纤维化。此外,DHZCP能恢复CCl4诱导组显著降低的GAS5的表达,并能显著抑制CCl4诱导的p-p38和p-Erk的表达,但对p-Jnk无抑制作用。当细胞过表达GAS5时,细胞增殖明显受阻。因此,DHZCP可以抑制p-p38和p-Erk的表达,而GAS5只能抑制p-Erk的表达。结论sdhzcp通过增加GAS5的表达抑制p-Erk,调节其他因子抑制p-p38来减轻肝纤维化。
{"title":"Effect of Dahuang Zhechong pills on long non-coding RNA growth arrest specific 5 in rat models of hepatic fibrosis","authors":"Gong Zhenghua ,&nbsp;Deng Chaowen ,&nbsp;Xiang Tianxin ,&nbsp;Tao Lili ,&nbsp;Xiao Hongbo ,&nbsp;Peng Yanzhong ,&nbsp;Zheng Jie ,&nbsp;Hu Guoxin","doi":"10.1016/j.jtcm.2018.04.007","DOIUrl":"10.1016/j.jtcm.2018.04.007","url":null,"abstract":"<div><h3>OBJECTIVE</h3><p>To investigate the involvement of growth arrest specific 5 (GAS5), a long non-coding RNA, in the anti-hepatic fibrosis process induced by Dahuang Zhechong pill (DHZCP) in rats.</p></div><div><h3>METHODS</h3><p>Thirty adult rats were divided into three groups, including a control group, a CCl<sub>4</sub>-induced fibrosis group and a DHZCP-treated fibrosis group. Hematoxylin-eosin and Masson staining were used for histopathological study. Serum enzymes, cytokines and cell proliferation were assayed using commercially available kits. A GAS5 lenti-virus vector was constructed to further investigate the role of GAS5 in the anti-hepatic fibrosis effect of DHZCP in rats.</p></div><div><h3>RESULTS</h3><p>Our results revealed that the proliferation of hepatic stellate cells cultured in serum derived from rats treated with DHZCP was significantly decreased, compared with cells treated with serum from the untreated rats. DHZCP alleviated the CCl<sub>4</sub>-induced hepatic fibrosis. Additionally, DHZCP can restore the expression of GAS5, which was significantly decreased in the CCl<sub>4</sub>-induced group, and markedly suppress the expression of p-p38 and p-Erk induced by CCl<sub>4,</sub> but not p-Jnk. Cell proliferation was significantly arrested when cells overexpressed GAS5. Thus, DHZCP can inhibit the expression of p-p38 and p-Erk, while GAS5 can only inhibit the expression of p-Erk.</p></div><div><h3>CONCLUSIONS</h3><p>DHZCP can alleviate hepatic fibrosis by increasing the expression of GAS5 to suppress p-Erk and regulating other factors to inhibit p-p38.</p></div>","PeriodicalId":17513,"journal":{"name":"Journal of Traditional Chinese Medicine","volume":"38 2","pages":"Pages 190-196"},"PeriodicalIF":2.6,"publicationDate":"2018-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jtcm.2018.04.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44625930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
期刊
Journal of Traditional Chinese Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1